Unicross Pharmaceuticals Private Limited
About Unicross Pharmaceuticals Private Limited
Data last updated:
Unicross Pharmaceuticals Private Limited was a private limited company based in Ahmedabad, Gujarat, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 12 September 2013.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ2013PTC076797. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Hiteshbhai Naranbhai Naiya and Ritesh Jayantilal Manani.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at 18 Hiramoti Chambers 2nd Floor Golwad Naka B/H Bank Of Baroda Khadia, Ahmedabad, Gujarat, India – 380001.
As per the financials filed for FY 2021, the company reported a revenue of ₹50,220, a decline of 89% compared to the previous year. For the same year it recorded a net loss of ₹2.1 Lakh (net margin -417.3%) and EBITDA of -₹2.1 Lakh (EBITDA margin -417.3%). Revenue has declined at a compounded annual rate (CAGR) of 66% over three years and 44% over five years.
Company details
Contact details
Unicross Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address18 Hiramoti Chambers 2nd Floor Golwad Naka B/H Bank Of Baroda Khadia, Ahmedabad, Gujarat, India – 380001
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Unicross Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Unicross Pharmaceuticals Private Limited
FY 2022 filings availableUnicross Pharmaceuticals Private Limited reported revenue of ₹50,220 (down 89% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 44% over five years, including a 89% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -417.3% | ||||
| Net Profit Margin | -417.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unicross Pharmaceuticals Private Limited, buy the company report.
Board of directors of Unicross Pharmaceuticals Private Limited
Unicross Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hiteshbhai Naranbhai Naiya | Director | 22 Nov 2013 | 12 Years 11 Months | As last reported |
| Ritesh Jayantilal Manani Also directs: Swyzer Nutrients Private Limited | Director | 12 Sep 2013 | 13 Years 1 Months | As last reported |
| Jayantibhai Devshibhai Manani | Director | 12 Sep 2013 | 13 Years 1 Months | As last reported |
Auditor
Unicross Pharmaceuticals Private Limited is audited by J N J & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J N J & ASSOCIATES | FY 2017 | 126660W |
Shareholding
The shareholding of Unicross Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Unicross Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unicross Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unicross Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unicross Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Unicross Pharmaceuticals Private Limited, buy the company report.
Recent activity
Unicross Pharmaceuticals Private Limited has 3 board changes on record since 2013: 3 appointments. The latest: Hiteshbhai Naranbhai Naiya was appointed as Director on 22 Nov 2013.
Frequently asked questions
Unicross Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Unicross Pharmaceuticals was a private limited company based in Ahmedabad, Gujarat, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 12 September 2013 and is registered under CIN U24232GJ2013PTC076797. The company has been struck off by the Registrar of Companies and is no longer operational.
Unicross Pharmaceuticals had 3 directors:
- Hiteshbhai Naranbhai Naiya - Director
- Ritesh Jayantilal Manani - Director
- Jayantibhai Devshibhai Manani - Director
The CIN (Corporate Identification Number) of Unicross Pharmaceuticals is U24232GJ2013PTC076797. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Unicross Pharmaceuticals is at 18 Hiramoti Chambers 2nd Floor Golwad Naka BH Bank Of Baroda Khadia, Ahmedabad, Gujarat, India – 380001.
Unicross Pharmaceuticals was incorporated on 12 September 2013. It is registered with the Registrar of Companies, Ahmedabad.
The latest financial statements of Unicross Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
No. Unicross Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Unicross Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
Hiteshbhai Naranbhai Naiya was appointed as Director on 22 Nov 2013. Jayantibhai Devshibhai Manani was appointed as Director on 12 Sep 2013. Ritesh Jayantilal Manani was appointed as Director on 12 Sep 2013.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
